Biblio Discovery — Demo Discovery Service

37 results for "Martin Posch"

Showing 1–20 · 3.08 seconds · RSS

  1. Journal Article

    Impact of adaptive filtering on power and false discovery rate in RNA-seq experiments

    Sonja Zehetmayer; Martin Posch; Alexandra Graf

    BMC Bioinformatics, Vol. 23 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background In RNA-sequencing studies a large number of hypothesis tests are performed to compare the differential expression of genes between several conditions. Filtering has been proposed to remove candidate genes with a low expression level which may not be relevant and have little or…

  2. Journal Article

    Evaluation of the Fill-it-up-design to use historical control data in randomized clinical trials with two arm parallel group design

    Stephanie Wied; Martin Posch; Ralf-Dieter Hilgers

    BMC Medical Research Methodology, Vol. 24 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Purpose In the context of clinical research, there is an increasing need for new study designs that help to incorporate already available data. With the help of historical controls, the existing information can be utilized to support the new study design, but of course, inclusion also…

  3. Journal Article

    Comparison of primary analysis strategies of randomized controlled trials with multiple endpoints with application to kidney transplantation

    Felix Herkner; Martin Posch; Gregor Bond et al.

    Scientific Reports, Vol. 16 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Relying on a single primary endpoint in randomized controlled trials (RCTs) is often infeasible, for example due to rare or heterogeneous events. Regulatory guidance therefore allows multiple endpoints, but different analytical strategies address different scientific questions and null…

  4. Journal Article

    An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis

    Peter Bauer; Jonas Brugger; Franz König et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract The number of reported coronavirus disease (COVID-19) deaths per 100,000 persons observed so far in 2020 is described in 15 European countries and the USA as dependent on age groups and sex. It is compared with the corresponding historic all-cause mortality per year depending on age and…

  5. Journal Article Full text

    Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials.

    Dominic Magirr; Thomas Jaki; Franz Koenig et al.

    PLoS ONE, Vol. 11 No. 2 · 2016 · English · DOAJ Scopus

    Mid-study design modifications are becoming increasingly accepted in confirmatory clinical trials, so long as appropriate methods are applied such that error rates are controlled. It is therefore unfortunate that the important case of time-to-event endpoints is not easily handled by the standard…

    Also available at: PLOS

  6. Journal Article Full text

    Subgroup identification in clinical trials via the predicted individual treatment effect.

    Nicolás M Ballarini; Gerd K Rosenkranz; Thomas Jaki et al.

    PLoS ONE, Vol. 13 No. 10 · 2018 · English · DOAJ Scopus

    Identifying subgroups of treatment responders through the different phases of clinical trials has the potential to increase success in drug development. Recent developments in subgroup analysis consider subgroups that are defined in terms of the predicted individual treatment effect, i.e. the…

    Also available at: PLOS

  7. Journal Article Full text

    Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program.

    Michal Hledík; Jitka Polechová; Mathias Beiglböck et al.

    PLoS ONE, Vol. 16 No. 7 · 2021 · English · DOAJ Scopus

    AimsMass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical…

    Also available at: PLOS

  8. Journal Article

    NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls

    Pavla Krotka; Katharina Hees; Peter Jacko et al.

    SoftwareX, Vol. 23 · 2023 · English · DOAJ Scopus

    Platform trials evaluate the efficacy of multiple treatments, allowing for late entry of the experimental arms and enabling efficiency gains by sharing controls. The power of individual treatment-control comparisons in such trials can be improved by utilizing non-concurrent controls (NCC) in the…

  9. Journal Article

    On the use of non-concurrent controls in platform trials: a scoping review

    Marta Bofill Roig; Cora Burgwinkel; Ursula Garczarek et al.

    Trials, Vol. 24 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Platform trials gained popularity during the last few years as they increase flexibility compared to multi-arm trials by allowing new experimental arms entering when the trial already started. Using a shared control group in platform trials increases the trial efficiency…

  10. Journal Article Full text

    Optimizing Trial Designs for Targeted Therapies

    Thomas Ondra; Sebastian Jobjörnsson; Robert A. Beckman et al.

    PLOS ONE, Vol. 11 No. 9 · 2016 · English · PLOS Scopus

    An important objective in the development of targeted therapies is to identify the populations where the treatment under consideration has positive benefit risk balance. We consider pivotal clinical trials, where the efficacy of a treatment is tested in an overall population and/or in a…

    Also available at: DOAJ

  11. Journal Article

    Factors associated with physician decision making on withholding cardiopulmonary resuscitation in prehospital medicine

    Paul Zajic; Philipp Zoidl; Marlene Deininger et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract This study seeks to identify factors that are associated with decisions of prehospital physicians to start (continue, if ongoing) or withhold (terminate, if ongoing) CPR in patients with OHCA. We conducted a retrospective study using anonymised data from a prehospital physician response…

  12. Journal Article

    Value of information methods to design a clinical trial in a small population to optimise a health economic utility function

    Michael Pearce; Siew Wan Hee; Jason Madan et al.

    BMC Medical Research Methodology, Vol. 18 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background Most confirmatory randomised controlled clinical trials (RCTs) are designed with specified power, usually 80% or 90%, for a hypothesis test conducted at a given significance level, usually 2.5% for a one-sided test. Approval of the experimental treatment by regulatory agencies…

  13. Journal Article

    Nationwide analysis of hospital admissions and outcomes of patients with SARS-CoV-2 infection in Austria in 2020 and 2021

    Paul Zajic; Michael Hiesmayr; Peter Bauer et al.

    Scientific Reports, Vol. 13 No. 1 · 2023 · English · DOAJ Scopus

    Abstract This retrospective study evaluated temporal and regional trends of patient admissions to hospitals, intensive care units (ICU), and intermediate care units (IMCU) as well as outcomes during the COVID-19 pandemic in Austria. We analysed anonymous data from patients admitted to Austrian…

  14. Journal Article

    Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency

    Olivier Collignon; Franz Koenig; Armin Koch et al.

    Trials, Vol. 19 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background In recent years, experience on the application of adaptive designs in confirmatory clinical trials has accumulated. Although planning such trials comes at the cost of additional operational complexity, adaptive designs offer the benefit of flexibility to update trial design and…

  15. Journal Article

    Efficiency of multivariate tests in trials in progressive supranuclear palsy

    Elham Yousefi; Mohamed Gewily; Franz König et al.

    Scientific Reports, Vol. 14 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Measuring disease progression in clinical trials for testing novel treatments for multifaceted diseases as progressive supranuclear palsy (PSP), remains challenging. In this study we assess a range of statistical approaches to compare outcomes as measured by the items of the progressive…